A genome-wide association study of methamphetamine use among people with HIV

BMC Medical Genomics

Table 3 Associations between previously reported SNPs and lifetime meth use in CNICS

Publication	Total Sample Size	Rs	Gene	Chr	Position	EA	NEA	EAF	Observed OR	Reported p-value	Observed p-value
Ikeda et al. [12]	1,100	rs4427170	SGCZ	8	14996272	T	A	0.28 (Meta) 0.41 (EUR) 0.45 (AMR) 0.15 (AFR)	1.05	3.9e-6	0.41 (Meta) 0.44 (EUR) 0.95 (AMR) 0.59 (AFR)
Chang et al. [11]	4,608	rs112706556	ANKS1B	12	99494606	A	G	0.19 (Meta) 0.17 (EUR) 0.18 (AMR) 0.21 (AFR)	0.96	1.5e-8	0.52 (Meta) 0.82 (AMR) 0.24 (EUR) 0.59 (AFR)

Reported p-value corresponds to the value reported in the original manuscript. Observed p-value corresponds to the p-value for that SNP found in our analysis. ‘Meta’ corresponds to the EAF and p-value found in the overall meta-analysis. EA Effect Allele, NEA Non-Effect Allele, OR Odds Ratio, EUR European Ancestry, AMR Admixed American Ancestry, AFR African Ancestry

ISSN: 1755-8794